A. Pericardial disease
B. Myocardial disease
C. Valve disease
D. Coronary artery disease
++++ = highly valuable; ++ = valuable; + = of interest; – = of limited interest.
A. PERICARDIAL DISEASE:
Effusion–screening and positive diagnosis |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| + |
| Cardiac CT |
| + |
| Stress echocardiography |
| – |
| ERNA/SPECT perfusion |
| +/– |
| A. Effusion–follow-up |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| – |
| Cardiac CT |
| – |
| Stress echocardiography |
| – |
| ERNA/SPECT perfusion |
| +/– |
| A. Constriction–screening and positive diagnosis |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| ++++ |
| Cardiac CT |
| ++ |
| Stress echocardiography |
| – |
| ERNA/SPECT perfusion |
| +/– |
B. MYOCARDIAL DISEASE:
LV systolic dysfunction |
| Echocardiography |
| ++++ (first-line imaging, contrast echocardiography if poor acoustic window) |
| Cardiac CMR |
| ++++ |
| Cardiac CT |
| + |
| Stress echocardiography |
| ++++ (contractile reserve assessment) |
| ERNA/SPECT perfusion |
| ++++/++++ (used when both function and perfusion are to be analysed) |
| B. LV diastolic dysfunction |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| + |
| Cardiac CT |
| – |
| Stress echocardiography |
| – |
| ERNA/SPECT perfusion |
| ++/+ |
| B. LV dysfunction–follow-up |
| Echocardiography |
| ++++ (first-line imaging, contrast echocardiography if poor acoustic window) |
| Cardiac CMR |
| + |
| Cardiac CT |
| – |
| Stress echocardiography |
| ++ (contractile reserve assessment) |
| ERNA/SPECT perfusion |
| ++/++ |
| B. Myocardial fibrosis |
| Echocardiography |
| – |
| Cardiac CMR |
| ++++ |
| Cardiac CT |
| + |
| Stress echocardiography |
| – |
| ERNA/SPECT perfusion |
| – |
C. VALVE DISEASE:
Positive diagnosis and severity assessment |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| ++ |
| Cardiac CT |
| – |
| Stress echocardiography |
| ++ |
| ERNA/SPECT perfusion |
| +/– |
| C. Follow-up |
| Echocardiography |
| ++++ |
| Cardiac CMR |
| – |
| Cardiac CT |
| – |
| Stress echocardiography |
| ++ |
| ERNA/SPECT perfusion |
| +/– |
D. CORONARY ARTERY DISEASE:
Positive diagnosis |
| Echocardiography |
| + (if resting wall–motion abnormalities) |
| Cardiac CMR |
| ++++ (stress CMRb) |
| Cardiac CT |
| ++ (CT angioa) |
| Stress echocardiography |
| ++++ (exercise or dobutamineb) |
| ERNA/SPECT perfusion |
| +/++++ |
| D. Follow-up |
| Echocardiography |
| + |
| Cardiac CMR |
| + |
| Cardiac CT |
| – |
| Stress echocardiography |
| ++++ (first-line imaging) |
| ERNA/SPECT perfusion |
| +/++ |
LV = left ventricular; CMR = cardiovascular magnetic resonance; CT = computed tomography.